Skip to main content
. 2018 Nov 20;47(Database issue):D1056–D1065. doi: 10.1093/nar/gky1133

Table 1.

Sources and evidence counts used for target-disease associations in the Open Targets Platform

Data source* Data type Evidence Count**
Genomics England PanelAPP (v2.2.0) Genetic associations 15 289
PheWAS catalogue (Sep-2017) Genetic associations 47 302
GWAS catalogue (July 2018) Genetic associations 101 511 (32 363)
UniProt (July 2018) Genetic associations 26 640 (21 870)
UniProt literature (July 2018) Genetic associations 4494
European Variation Archive∧ (July 2018) Genetic associations 73 805 (28 050)
Gene2Phenotype (May 2017) Genetic associations 1604 (975)
UniProt (July 2018) Somatic mutations 282
Cancer Gene Census (COSMIC v85) Somatic mutations 55 963 (23 440)
IntOGen (December 2014) Somatic mutations 2371 (2377)
European Variation Archive∧ (July 2018) Somatic mutations 7624 (456)
ChEMBL (v24) Drugs 410 436 (120 520)
Reactome (v65) Affected pathways 9735 (6143)
PROGENy (April 2018) Affected pathways 308
SLAPenrich (August 2017) Affected pathways 89 661
Expression Atlas (February 2018) Expression 288 273 (529 084)
Europe PMC (July 2018) Text mining 4 906 527 (3 678 967)
PhenoDigm (November 2017) Animal model 465 887 (395 331)

*Database version (or date) in parentheses.

**As per 18.08 release of the Open Targets Platform. Parentheses show the number (in italics) of evidence count reported previously (3). Note, the reduction in the number of evidence from Expression Atlas (see main text for explanation).

∧Containing ClinVar data from May 2017.

Detailed target-disease association counts can be found in the Supplementary Table.

Data sources in bold are new data, whereas the remaining sources have been described in our first publication and shown here are updates from the previous report.